Product Information
LEVOTHYROXINE 300 MCG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.1084 per EA under NDC 31722029590. Its NADAC has been published 142 times since Oct 11, 2023.
Strength
.3 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722029590
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LEVOTHYROXINE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA215259On Market Since
1/18/2023
Pharmacological Classes
Price Statistics
The NADAC for LEVOTHYROXINE 300 MCG TABLET has been published 142 times since Oct 11, 2023, and over the history we have for it it has declined 4.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1084 per EA |
|---|---|
| All-time high | $0.1708 (Apr 10, 2024) |
| All-time low | $0.0715 (Jul 17, 2024) |
| 52-week high | $0.1278 |
| 52-week low | $0.1084 |
| Median price | $0.1204 |
| Average price | $0.1213 |
| Largest weekly change | +78.9% (Aug 21, 2024) |
| Weeks tracked | 142 |
| Tracking since | Oct 11, 2023 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LEVOTHYROXINE 300 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVOTHYROXINE 300 MCG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.1084 per EA (NDC 31722029590), effective Jun 24, 2026.
How has the price of LEVOTHYROXINE 300 MCG TABLET changed over time?
Over the history we have for it, the NADAC for LEVOTHYROXINE 300 MCG TABLET has declined 4.4%. It has been tracked across 142 weekly CMS publications since Oct 11, 2023.
What are the highest and lowest recorded NADAC prices for LEVOTHYROXINE 300 MCG TABLET?
Since Oct 11, 2023, the NADAC for LEVOTHYROXINE 300 MCG TABLET has ranged from a low of $0.0715 (Jul 17, 2024) to a high of $0.1708 (Apr 10, 2024), with a median of $0.1204 per EA.
Are there cheaper alternatives to LEVOTHYROXINE 300 MCG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as LEVOTHYROXINE 300 MCG TABLET, but none are currently priced below it.
Who manufactures LEVOTHYROXINE 300 MCG TABLET?
LEVOTHYROXINE 300 MCG TABLET (NDC 31722029590) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification